Companies: 10,795·Total market cap: $144.5T
Adynxx, Inc.

Adynxx, Inc.

ADYXOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$581
P/E Ratio
52W High$0.0002
52W Low$0.0001

Adynxx, Inc. (ADYX) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

adyx · pe ratio · data through Dec 31, 2018

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Adynxx, Inc. (ADYX) measures how much investors pay for each dollar of the company's trailing earnings. ADYX's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$10.26.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2018-12-31

Forward P/E
N/A
FY2028 est. EPS $-0.54
Based on 1 analyst
EPS (TTM)
-$10.26
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Adynxx, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

1999 – 2018 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Adynxx, Inc.
Adynxx, Inc.You
ADYX
$0MN/A-$10.26
BG Medicine, Inc.
BG Medicine, Inc.
BGMD
$0MN/A-$0.55
BIMI International Medical Inc.
BIMI International Medical Inc.
BIMI
$0MN/A-$8.40
Bionik Laboratories Corp.
Bionik Laboratories Corp.
BNKL
$0MN/A-$0.72
ContraFect Corporation
ContraFect Corporation
CFRXQ
$0MN/A-$124.97
eFFECTOR Therapeutics, Inc.
eFFECTOR Therapeutics, Inc.
EFTR
$0MN/A-$16.37
FusionPharm, Inc.
FusionPharm, Inc.
FSPM
$0MN/A

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 20 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2018-12-31Latest
FY2018
$-10.26
2017-12-31
FY2017
$-35.94
2016-12-31
FY2016
$-60.60
2015-12-31
FY2015
$-67.69
2014-12-31
FY2014
$-104.36
2013-12-31
FY2013
$-184.66
2012-12-31
FY2012
$-54.67
2011-12-31
FY2011
$-175.55
2010-12-31
FY2010
$-52.13
2009-12-31
FY2009
$-26.04

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Adynxx, Inc. (ADYX) measures how much investors pay for each dollar of the company's trailing earnings. ADYX's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$10.26.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$10.26 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

ADYX pe ratio · 6 questions

ADYX's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.00 and TTM EPS of -$10.26. Data sourced from Financial Modeling Prep via ADYX's SEC 10-K and 10-Q filings.

ADYX PE ratioWhat is ADYX PE ratioCurrent PE ratio of ADYXADYX PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Adynxx, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08